Literature DB >> 3175472

Histological examination of onchocercomata after therapy with ivermectin.

E J Albiez1, G Walter, A Kaiser, P Ranque, H S Newland, A T White, B M Greene, H R Taylor, D W Büttner.   

Abstract

During chemotherapy trials in hyperendemic onchocerciasis areas in West Africa 15 adult nodule carriers in Liberia and 24 patients in Mali received single doses of ivermectin (150 or 200 micrograms/kg). Nodules were extirpated two, six and ten months after therapy and examined histologically. No macrofilaricidal effect of ivermectin was observed. Two months after therapy, in 93% of all female worms with intrauterine stretched microfilariae nearly all microfilariae were degenerated. The percentage was lower after ten months but still significantly higher than in untreated control groups. Ivermectin did not cause degeneration of the intrauterine coiled microfilariae. But the percentage of the female worms with coiled microfilariae was significantly lower two and ten months after therapy than that in the placebo or untreated control groups. Correspondingly, the percentage of nodules with intact microfilariae in the nodule tissue was also significantly lower throughout the examination period than that of the untreated control groups. There was not observed any effect on the spermatogenesis and spermatozoa were found frequently in the uteri of female worms. Using the method of histology, the long lasting inhibitory effect of a single dose of ivermectin on the intrauterine production of microfilariae could clearly be demonstrated. This proves the value of histology for the assessment of drug effects on adult O. volvulus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3175472

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  15 in total

Review 1.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin.

Authors:  B O Duke; M C Pacqué; B Muñoz; B M Greene; H R Taylor
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 3.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.

Authors:  K L Goa; D McTavish; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

4.  An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus.

Authors:  J D Edgeworth; A Abiose; B R Jones
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 5.  Onchocerciasis.

Authors:  H R Taylor
Journal:  Int Ophthalmol       Date:  1990-05       Impact factor: 2.031

Review 6.  Treatment of onchocerciasis.

Authors:  Y Van Laethem; C Lopes
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

7.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Authors:  Achim Hoerauf; Sabine Specht; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Sabine Mand; Linda Batsa; Norbert Brattig; Peter Konadu; Claudio Bandi; Rolf Fimmers; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

8.  Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility.

Authors:  A Hoerauf; K Nissen-Pähle; C Schmetz; K Henkle-Dührsen; M L Blaxter; D W Büttner; M Y Gallin; K M Al-Qaoud; R Lucius; B Fleischer
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Authors:  Achim Hoerauf; Sabine Specht; Marcelle Büttner; Kenneth Pfarr; Sabine Mand; Rolf Fimmers; Yeboah Marfo-Debrekyei; Peter Konadu; Alexander Yaw Debrah; Claudio Bandi; Norbert Brattig; Anna Albers; John Larbi; Linda Batsa; Mark J Taylor; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2007-11-13       Impact factor: 3.402

10.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.